Search results
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
Prof Nicolas Van Mieghem and Dr Joost Daemen return with their critical review series, View from the Thoraxcenter, to preview the most anticipated late-breaking and featured science trials of ACC.23.
Which trials have the potential to change practice? What are the key considerations for patient care and research? What is the context of the top trials of ACC?
Trials covered in detail include:
…
View more
Lars Søndergaard
Research Area(s) / Expertise:
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
Prof Nicolas Van Mieghem and Dr Joost Daemen interprets the findings from the top 10 ACC.23/WCC late-breaking and featured science trials and studies in their critical View from the Thoraxcenter review series. Join them as they consider the implications for research and offer an insight into how they will incorporate the latest data into their day-to-day clinical practice.
What are the top…
View more
Author(s):
Kendra J Grubb
,
Tamim Nazif
,
Mathew R Williams
,
et al
Added:
3 years ago
Concomitant coronary artery disease (CAD) and valvular heart disease is a common problem in the ageing population. It is estimated that the prevalence of mitral regurgitation and aortic stenosis in individuals over the age of 70 is 10 % and 4 %, respectively.1,2 Among patients presenting with symptomatic aortic stenosis, concurrent CAD occurs in over 50 % of those over 70 years of age and over 65…
View more
Author(s):
Constantinos O’Mahony
,
Saidi Mohiddin
,
Charles Knight
Added:
3 years ago
Hypertrophic cardiomyopathy (HCM) is a genetic disorder of cardiac muscle with a heterogeneous clinical course.1 The disease is clinically characterised by left ventricular hypertrophy (LVH), which is typically asymmetric, and a subgroup of patients have left ventricular outflow tract obstruction (LVOTO) caused by systolic anterior motion (SAM) of the mitral valve leaflet(s).2,3 LVOTO is often…
View more
Author(s):
Nina Wunderlich
,
Jennifer Franke
,
Neil Wilson
,
et al
Added:
3 years ago
Imaging guidance is of major importance for successful outcomes in the interventional treatment of structural, congenital and valvular heart disease. Cardiac transcatheter treatment of these diseases is a rapidly growing field and, as a result, there has been substantial progress in image-guidance technology.
During interventions, the major imaging focus is currently on echocardiography, which…
View more
TAVI Update: ESC Symposium
Author(s):
Alec Vahanian
,
Volkmar Falk
,
Nicole Karam
,
et al
Start date:
Aug 29, 2021
Broadcast
Author(s):
Crochan J O’Sullivan
,
Peter Wenaweser
Added:
3 years ago
Since the first ‘proof-of-concept’ case of transcatheter aortic valve implantation (TAVI) was reported by Cribier and colleagues in 2002, more than 200,000 patients have undergone the procedure in approximately 65 countries.1,2 Since its inception, the majority of patients undergoing TAVI have been considered inoperable or high risk for conventional surgical aortic valve replacement (SAVR) as…
View more
Martin Swaans
Author
Foreword
Author(s):
Simon Kennon
Added:
3 years ago
Article